Skip to main content
Caplight Logo









uMotif

uMotif

Private
LondonHealthcare & Life Scienceshttps://umotif.com/

Last Round

Growth Equity

May 25, 2022

Total Funding Raised

$32.15M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

uMotif is a healthcare technology company that provides a patient-centric eCOA/ePRO and engagement platform for clinical research and real-world studies.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Patient Engagement, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

eCOAePROelectronic clinical outcome assessmentselectronic patient-reported outcomesdecentralized clinical trialsDCTpatient engagement platformclinical trial softwareeClinical technologyhybrid clinical trialseConsentpatient-centric data captureclinical trial managementwearable integrationtrial tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

uMotif Comparables

Compare uMotif with similar companies based on industry and business-model similarity.

uMotif comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
YPrime
86%
Clinical Ink
85%
Medrio
84%

uMotif Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityMay 25, 2022
Series ASep 3, 2020
VC RoundJun 26, 2018

Key People

Founding team and executive leadership

Bruce Hellman

Co-Founder & Chief Patient Officer at uMotif

Founding Team

John Barron

Chief Technology Officer

Executive Team

Gary Parrott

Chief Financial Officer

Executive Team

uMotif Investors

Notable investors and investment history

uMotif investors
InvestorRounds
Athyrium Capital ManagementGrowth Equity
Albion CapitalVC Round
Albion CapitalGrowth Equity, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2026

    COO Andrea Valente promoted to CEO, succeeding Steve Rosenberg.

  • Apr 23, 2026

    Steve Rosenberg, the company's CEO, is retiring.

uMotif Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

uMotif Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about uMotif's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range99
Year Founded2012
Last FundingMay 25, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?